Skip to main content

Table 4 Association of measures of adiposity with progressive eGFR decline

From: Lipid accumulation product, visceral adiposity index and risk of chronic kidney disease

 

Events/N

Proportion

Unadjusted

Model 1

Model 2

Model 3

OR (95% CI)

OR (95% CI)

OR (95% CI)

OR (95% CI)

VAI

 Continuous (per doubling)

1452/12624

12%

1.23 (1.17, 1.31)

1.31 (1.23, 1.38)

1.14 (1.07, 1.21)

1.11 (1.04, 1.18)

 Quartiles

  ≤ 2.31

306/3304

9%

1.00 (ref)

1.00 (ref)

1.00 (ref)

1.00 (ref)

  2.32–3.64

355/3275

11%

1.18 (1.00, 1.39)

1.16 (0.98, 1.38)

1.02 (0.86, 1.22)

1.02 (0.86, 1.22)

  3.65–5.91

378/3143

12%

1.37 (1.17, 1.62)

1.43 (1.22, 1.69)

1.16 (0.97, 1.37)

1.14 (0.95, 1.35)

  ≥ 5.92

413/2902

14%

1.62 (1.37, 1.90)

1.83 (1.55, 2.16)

1.27 (1.07, 1.51)

1.20 (1.00, 1.44)

LAP

 Continuous (per doubling)

1452/12624

12%

1.35 (1.28, 1.43)

1.42 (1.34, 1.50)

1.21 (1.14, 1.29)

1.18 (1.11, 1.26)

 Quartiles

  ≤ 124.89

264/3311

8%

1.00 (ref)

1.00 (ref)

1.00 (ref)

1.00 (ref)

  124.9–208.07

340/3305

10%

1.29 (1.08, 1.53)

1.20 (1.01, 1.43)

1.05 (0.88, 1.25)

1.06 (0.88, 1.26)

  208.08–339.57

406/3107

13%

1.71 (1.44, 2.02)

1.65 (1.39, 1.96)

1.30 (1.09, 1.54)

1.30 (1.09, 1.56)

  ≥ 339.58

442/2901

15%

2.06 (1.75, 2.44)

2.25 (1.90, 2.66)

1.45 (1.22, 1.74)

1.36 (1.13, 1.63)

BMI

 Continuous (per doubling)

1452/12624

12%

2.83 (2.32, 3.45)

3.19 (2.58, 3.95)

1.89 (1.50, 2.37)

1.79 (1.42, 2.25)

 Quartiles

  ≤ 25.1

238/3042

8%

1.00 (ref)

1.00 (ref)

1.00 (ref)

1.00 (ref)

  25.2–28.3

337/3338

10%

1.29 (1.08, 1.55)

1.29 (1.08, 1.55)

1.18 (0.98, 1.42)

1.22 (1.01, 1.47)

  28.4–32.5

389/3271

12%

1.61 (1.36, 1.92)

1.64 (1.37, 1.95)

1.32 (1.1.0, 1.59)

1.33 (1.10, 1.60)

  > 32.5

488/2973

16%

2.29 (1.93, 2.71)

2.44 (2.05, 2.91)

1.67 (1.38, 2.01)

1.63 (1.34, 1.97)

Waist Circumference

 Continuous (per doubling)

1452/12624

12%

4.22 (3.26, 5.48)

5.16 (3.91, 6.81)

2.42 (1.80, 3.25)

2.21 (1.64, 2.99)

 Quartiles

  ≤ 86.3

307/3739

8%

1.00 (ref)

1.00 (ref)

1.00 (ref)

1.00 (ref)

  86.4–95.2

298/2936

10%

1.20 (1.01, 1.43)

1.23 (1.03, 1.48)

1.07 (0.89, 1.29)

1.12 (0.93, 1.34)

  95.3–105.4

375/3172

12%

1.44 (1.23, 1.70)

1.53 (1.29, 1.81)

1.20 (1.01, 1.43)

1.20 (1.00, 1.44)

  > 105.4

472/2777

17%

2.27 (1.94, 2.66)

2.51 (2.13, 2.96)

1.63 (1.37, 1.95)

1.58 (1.32, 1.89)

  1. Model 1: adjusted for age, sex, race
  2. Model 2: Model 1 + prevalent CHD, prevalent stroke, HTN, DM, smoking status
  3. Model 3: Model 2+ eGFR, UACR
  4. Abbreviations: VAI visceral adiposity index, LAP lipid accumulation product, BMI body mass index, CHD coronary heart disease, HTN hypertension, DM diabetes mellitus, eGFR estimated glomerular filtration rate, UACR urine albumin-to-creatinine ratio